Search results
21 sie 2018 · The USPSTF found convincing evidence that screening with cervical cytology alone, primary testing for high-risk HPV types (hrHPV testing) alone, or in combination at the same time (cotesting) can detect high-grade precancerous cervical lesions and cervical cancer.
10 mar 2022 · The Task Force is updating its recommendation on cervical cancer screening based on new evidence. See the current final recommendation, the draft research plan, and the opportunity for comment.
21 sie 2018 · This article reviews the benefits and harms of cervical cancer screening with high-risk human papillomavirus (hrHPV) testing alone or in combination with cytology (Pap test) compared with cytology alone. It provides evidence from randomized trials and cohort studies to inform the USPSTF recommendation on cervical cancer screening.
ACOG joins ASCCP and SGO in endorsing the USPSTF recommendations for cervical cancer screening in average-risk individuals aged 30–65 years. The guidelines include primary hrHPV testing, cytology alone, and co-testing as options, and recommend screening initiation at age 21 years.
17 maj 2024 · Learn about cervical cancer screening methods, recommendations, and exceptions from the United States Preventive Services Task Force (USPSTF). Find out how often you should get screened, where to get tested, and what to expect during a cervical cancer screening test.
Cervicovaginal HPV testing involves checking for the presence of 13 cancer-causing types of HPV in a collection of cells obtained from a swab of the cervix or vagina. HPV testing is approximately 90% accurate for detection of precancer.
18 wrz 2020 · ACS recommends cervical cancer screening with an HPV test alone every 5 years for everyone with a cervix from age 25 until age 65. If HPV testing alone is not available, people can get screened with an HPV/Pap cotest every 5 years or a Pap test every 3 years.
